Alan Arnette has announced that he has summitted Mr. Elbrus in Russia.
Alan posted an audio dispatch this morning announcing the summit and said it took the team about 7.5 hours to get up to the West Summit. Mt. Elbrus is the fifth climb in The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign.
Alan asks that people pledge a penny per foot for the climb, or about $100 for Elbrus, to go to Cure Alzheimer’s Fund, National Family Caregivers Association and the Alzheimer’s Association.
Dr. Sam Gandy, a Cure Alzheimer's Fund Consortium Research Member, was recently asked to comment on an Alzheimer's therapy study featured in the journal Nature. Dr. Gandy, an associate director at the Mount Sinai Alzheimer's Disease Research Center in New York, has been featured in Nature on numerous occasions for his knowledge and expertise in Alzheimer's disease research and treatment.
Glenn Caffery, who is running across the country to raise money and awareness for Alzheimer's research, was recently mentioned in an article in the Record-Journal in Meriden, Conn. Also profiled was Glenn's mother, Dolores, who said in the article she is constantly checking his whereabouts on her computer.
Glenn started his run on May 19 in Seaside, Ore., and is currently in Ann Arbor, Mich. Glenn plans to finish his run in Westerly, R.I., in early August. All of the money that he raises will be donated to Cure Alzheimer's Fund.
Congressman Ed Markey (D-MA) and Senator Barbara Mikulski (D-MD) have introduced resolutions urging the United States Postal Service to issue a stamp to fund Alzheimer’s disease research at the National Institutes of Health. The “semipostal” stamp would have its proceeds specifically directed for additional Alzheimer’s disease research through the NIH.
On January 6, an article by Robert C. Malenka and Roberto Malinow was published in the journal Nature. Malenka and Malinow's article, both of whom are Cure Alzheimer's Fund Research Consortium Members, focused on recent research surrounding the causes of Alzheimer's and studies in mice that have pinpointed specific regions and proteins within the brain thought to be associated with the disease.
Dr. Sam Gandy, a CAF Research Consortium member, and Rachel Lane, a postdoctoral researcher in Gandy's lab, presented their findings today at the Alzheimer's Annual International Conference in Paris. Their research identified a gene, called SorCS1, that is for a protein that can cause Type 2 diabetes and also may kill nerve cells in the brain, thus contributing to Alzheimer's.
According to a statement released by Mount Sinai School of Medicine in New York, where Dr. Gandy is the Associate Director of the Alzheimer's Disease Research Center:
Dr. Sam Gandy's article, entitled "Prevention is Better than Cure," was featured last week in the journal Nature. NBC highlighted Dr. Gandy's perspective and research in an interview on the nightly news and on their website. Gandy, who is a CAF Research Consortium member, will be sending members of his lab to Paris this week to attend the Alzheimer's Association's Annual International Conference.
On Wednesday, July 13, Dr. Sam Gandy's commentary regarding the early treatment of Alzheimer's was featured in a weekly press release sent out by Nature. Gandy, a CAF research consortium member, submitted a Perspective column addressing the need for early testing.